| 1 |
Jayne DG,Fook S,Loi C, et al. Peritoneal carcinomatosis from colorectal cancer [J]. The British Journal of Surgery, 2002, 89(12): 1545-1550.
|
| 2 |
Sadeghi B,Arvieux C,Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study [J]. Cancer, 2000, 88(2): 358-363.
|
| 3 |
Chua TC,Morris DL,Saxena A, et al. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study [J]. Annals of Surgical Oncology, 2011, 18(6): 1560-1567.
|
| 4 |
Pelz JO,Vetterlein M,Grimmig T, et al. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia [J]. Annals of Surgical Oncology, 2013, 20(4): 1105-1113.
|
| 5 |
Rampone B. Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer [J]. World Journal of Gastroenterology, 2010, 16(11): 1299.
|
| 6 |
Baratti D,Kusamura S,Iusco D, et al. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases [J]. Annals of Surgical Oncology, 2017, 24(1): 167-175.
|
| 7 |
Turaga K,Levine E,Barone R, et al. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States [J]. Annals of Surgical Oncology, 2014, 21(5): 1501-1505.
|
| 8 |
Elias DM,Sideris L. Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis [J]. Surgical Oncology Clinics of North America, 2003, 12(3): 755-769.
|
| 9 |
Zani S,Papalezova K,Stinnett S, et al. Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy [J]. Journal of Surgical Oncology, 2013, 107(4): 307-311.
|
| 10 |
Francescutti V,Rivera L,Seshadri M, et al. The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis [J]. Oncology Reports, 2013, 30(1): 35-42.
|
| 11 |
Elias D,Lefevre JH,Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin [J]. Journal of Clinical Oncology, 2009, 27(5): 681-685.
|
| 12 |
Huang CQ,Yang XJ,Yu Y, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center [J]. PloS one, 2014, 9(9): e108509.
|
| 13 |
Leung V,Huo YR,Liauw W ,et al. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis [J]. European Journal of Surgical Oncology, 2017, 43(1): 144-149.
|
| 14 |
Sugarbaker PH,Schellinx ME,Chang D, et al. Peritoneal carcinomatosis from adenocarcinoma of the colon [J]. World Journal of Surgery, 1996,20(5): 585-591,discussion 92.
|
| 15 |
da Silva RG,Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer [J]. Journal of the American College of Surgeons, 2006, 203(6): 878-886.
|
| 16 |
Glehen O,Cotte E,Schreiber V, et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin [J]. The British Journal of Surgery, 2004, 91(6): 747-754.
|
| 17 |
Simkens GA,van Oudheusden TR,Luyer MD, et al. Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis [J]. Annals of Surgical Oncology, 2015, 22(8): 2656-2662.
|
| 18 |
Pelz JO,Doerfer J,Decker M, et al. Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model [J]. International Journal of Colorectal Disease, 2007, 22(8): 941-947.
|
| 19 |
Aghayeva A,Benlice C,Bilgin IA, et al. The effects of hyperthermic intraperitoneal chemoperfusion on colonic anastomosis: an experimental study in a rat model [J]. Tumori, 2017, 103(3): 307-313.
|
| 20 |
Simkens GA,van Oudheusden TR,Braam HJ, et al. Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters [J]. Annals of Surgical Oncology, 2016, 23(1): 99-105.
|
| 21 |
Maciver AH,Lee N,Skitzki JJ, et al. Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms [J]. European Journal of Surgical Oncology, 2017, 43(6): 1028-1039.
|